Page 64 - IMO-1-1
P. 64

Innovative Medicines & Omics                                         Antioxidant nanomedicines for therapies



                doi: 10.1002/adma.202210144                    258.  Zhang  S,  Li  Y,  Sun  S,  et al.  Single-atom  nanozymes
                                                                   catalytically surpassing naturally occurring enzymes
            247.  Maas  AIR,  Stocchetti  N,  Bullock  R.  Moderate  and
                severe  traumatic  brain  injury  in  adults.  Lancet Neurol.   as  sustained  stitching  for  brain  trauma.  Nat Commun.
                                                                   2022;13(1):4744.
                2008;7(8):728-741.
                                                                   doi: 10.1038/s41467-022-32411-z
                doi: 10.1016/S1474-4422(08)70164-9
                                                               259.  Huang  B,  Tang  T,  Chen  SH,  et al.  Near-infrared-IIb
            248.  Rodriguez-Rodriguez  A,  Egea-Guerrero  JJ,  Murillo-  emitting single-atom catalyst for imaging-guided therapy
                Cabezas F, Carrillo-Vico A. Oxidative stress in traumatic   of  blood-brain  barrier  breakdown  after  traumatic  brain
                brain injury. Curr Med Chem. 2014;21(10):1201-1211.
                                                                   injury. Nat Commun. 2023;14(1):197.
                doi: 10.2174/0929867321666131217153310
                                                                   doi: 10.1038/s41467-023-35868-8
            249.  Greve MW, Zink BJ. Pathophysiology of traumatic brain   260.  Honda T, Hirakawa Y, Nangaku M. The role of oxidative
                injury. Mt Sinai J Med. 2009;76(2):97-104.         stress and hypoxia in renal disease. Kidney Res Clin Pract.
                doi: 10.1002/msj.20104                             2019;38(4):414-426.
            250.  Boyd  BJ,  Galle  A,  Daglas  M,  Rosenfeld  JV,  Medcalf  R.      doi: 10.23876/j.krcp.19.063
                Traumatic brain injury opens blood-brain barrier to stealth   261.  Kamaly  N,  He  JC,  Ausiello  DA,  Farokhzad  OC.
                liposomes via an enhanced permeability and retention   Nanomedicines for renal disease: Current status and future
                (EPR)-like effect. J Drug Target. 2015;23(9):847-853.
                                                                   applications. Nat Rev Nephrol. 2016;12(12):738-753.
                doi: 10.3109/1061186X.2015.1034280
                                                                   doi: 10.1038/nrneph.2016.156
            251.  Yoo  D,  Magsam  AW,  Kelly  AM,  Stayton  PS,  Kievit  FM,   262.  Du  BJ,  Yu  MX,  Zheng  J.  Transport  and  interactions  of
                Convertine  AJ.  Core-cross-linked  nanoparticles  reduce   nanoparticles in the kidneys. Nat Rev Mater. 2018;3(10):358-374.
                neuroinflammation and improve outcome in a mouse model
                of traumatic brain injury. ACS Nano. 2017;11(9):8600-8611.     doi: 10.1038/s41578-018-0038-3
                doi: 10.1021/acsnano.7b03426                   263.  Bellomo  R,  Kellum  JA,  Ronco  C.  Acute  kidney  injury.
                                                                   Lancet. 2012;380(9843):756-766.
            252.  Bitner BR, Marcano DC, Berlin JM, et al. Antioxidant carbon
                particles  improve  cerebrovascular  dysfunction  following      doi: 10.1016/S0140-6736(11)61454-2
                traumatic brain injury. ACS Nano. 2012;6(9):8007-8014.  264.  Thadhani R, Pascual M, Bonventre JV. Acute renal failure.
                doi: 10.1021/nn302615f                             N Engl J Med. 1996;334(22):1448-1460.
            253.  Ali  SS,  Hardt  JI,  Quick  KL,  et al.  A  biologically  effective      doi: 10.1056/NEJM199605303342207
                fullerene (C60) derivative with superoxide dismutase mimetic   265.  Paller  MS,  Hoidal  JR,  Ferris  TF.  Oxygen  free  radicals
                properties. Free Radic Biol Med. 2004;37(8):1191-1202.  in  ischemic  acute  renal  failure  in  the  rat.  J  Clin Invest.
                doi: 10.1016/j.freeradbiomed.2004.07.002           1984;74(4):1156-1164.

            254.  Mu  X,  Wang  J,  Li  Y,  et  al.  Redox  trimetallic  nanozyme      doi: 10.1172/JCI111524
                with neutral environment preference for brain injury. ACS   266.  Star  RA.  Treatment  of  acute  renal  failure.  Kidney Int.
                Nano. 2019;13(2):1870-1884.                        1998;54(6):1817-1831.
                doi: 10.1021/acsnano.8b08045                       doi: 10.1046/j.1523-1755.1998.00210.x
            255.  Mu X, Wang J, He H, et al. An oligomeric semiconducting   267.  Rushworth  GF,  Megson  IL.  Existing  and  potential
                nanozyme with ultrafast electron transfers alleviates acute   therapeutic  uses  for  N-acetylcysteine:  The  need  for
                brain injury. Sci Adv. 2021;7(46):eabk1210.        conversion to intracellular glutathione for antioxidant
                doi: 10.1126/sciadv.abk1210                        benefits. Pharmacol Ther. 2014;141(2):150-159.
            256.  Chang B, Zhang L, Wu S, Sun Z, Cheng Z. Engineering      doi: 10.1016/j.pharmthera.2013.09.006
                single-atom  catalysts  toward  biomedical  applications.   268.  Jiang D, Ge Z, Im HJ, et al. DNA origami nanostructures
                Chem Soc Rev. 2022;51(9):3688-3734.                can exhibit preferential renal uptake and alleviate acute
                doi: 10.1039/d1cs00421b                            kidney injury. Nat Biomed Eng. 2018;2(11):865-877.
            257.  Liu H, Li Y, Sun S, et al. Catalytically potent and selective      doi: 10.1038/s41551-018-0317-8
                clusterzymes for modulation of neuroinflammation   269.  Hou J, Wang H, Ge Z, et al. Treating acute kidney injury
                through  single-atom  substitutions.  Nat Commun.   with  antioxidative  black  phosphorus  nanosheets.  Nano
                2021;12(1):114.                                    Lett. 2020;20(2):1447-1454.
                doi: 10.1038/s41467-020-20275-0                    doi: 10.1021/acs.nanolett.9b05218


            Volume 1 Issue 1 (2024)                         58                               doi: 10.36922/imo.2527
   59   60   61   62   63   64   65   66   67   68   69